Jeremy is responsible for shaping and delivering against our policy goals on issues such as pandemic preparedness, vaccines, drug-resistant infections and disease surveillance. Within Wellcome, he provides a bridging point between our Policy team and colleagues managing our research activities and investments in infectious diseases. He also works extensively with external partners who share Wellcome’s interests in this space – across academia, civil society, international organisations, and the private sector.
Before joining Wellcome in 2017, he spent much of his career working for the UK government in policy roles dealing with public and global health and emergency preparedness. This includes time spent on secondment to Wellcome, as part of the team supporting Lord Jim O’Neill on his policy-focused Review on Antimicrobial Resistance, commissioned by the UK Prime Minister in 2014. Jeremy is originally from the North-East of England. He has a BSc in Economics from the University of Nottingham and a Master’s in Health Policy from Imperial College London.
